Amezinium metilsulfate

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H12N3O.CH3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03NR868ICX, chemically known as pyridazinium, 4-amino-6-methoxy-1-phenyl-, methyl sulfate but generally known as amezinium methyl sulfate, which bears US NIH Compound Identifier 71926. European Medicines Agency schedules Amezinium metilsulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05412MIG. The term AMEZINIUM METILSULFATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules amezinium methyl sulfate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule amezinium metilsulfate under HS 29339990 and SITC 51577. As of Q4 2014, AMEZINIUM METILSULFATE remains the US FDA Preferred Term for this commodity. Amezinium metilsulfate bears US NLM identifiers UMLS ID C0771147 and NCI Concept Code C72918. SMILES: COC1=[N+](N=CC(=C1)N)C2=CC=CC=C2.COS(=O)(=O)[O-].